| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/05/2001 | WO2001047898A2 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp) |
| 07/05/2001 | WO2001047897A1 Cytokine, especially tnf-alpha, inhibitors |
| 07/05/2001 | WO2001047893A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias |
| 07/05/2001 | WO2001047892A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | WO2001047891A1 Heterocyclic compounds having sulfonamide groups |
| 07/05/2001 | WO2001047890A1 Quinoline and quinazoline derivatives and drugs containing the same |
| 07/05/2001 | WO2001047887A1 β-AMINO ACID COMPOUNDS AS INTEGRIN ANTAGONISTS |
| 07/05/2001 | WO2001047885A1 Substituted indole mannich bases |
| 07/05/2001 | WO2001047883A1 Fused-ring compounds and use thereof as drugs |
| 07/05/2001 | WO2001047880A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047878A1 Substituted pyrrole mannich bases to combat pain and allergic reactions |
| 07/05/2001 | WO2001047507A2 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 07/05/2001 | WO2001009094A3 Chemokine receptor antagonists and methods of use therefor |
| 07/05/2001 | WO2000078745A3 Crystalline form of (r)-2-[[[3-methyl- 4- (2,2,2,- trifluoroethoxy) -2- pyridinyl] methyl] sulfinyl] -1h-benzimidazole |
| 07/05/2001 | WO2000073278A3 5-phenyl-pyrimidine derivatives |
| 07/05/2001 | WO2000068195A3 Substituted pyrrolidines as cell adhesion inhibitors |
| 07/05/2001 | WO2000055137A8 Compounds and methods for modulation of estrogen receptors |
| 07/05/2001 | US20010007038 Catalyst is derivative of hydroxybenzotriazole, formed using carbodiimides as amide coupling agents; high purity |
| 07/05/2001 | US20010006973 1-oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels |
| 07/05/2001 | US20010006969 Pyrimidine nucleus-containing compound and a medicament containing the same for a blood oxygen partial pressure amelioration, and a method for preparing the same |
| 07/05/2001 | DE19963178A1 Substituierte Indol-Mannichbasen Substituted indole Mannich bases |
| 07/05/2001 | CA2396693A1 Cytokine, especially tnf-alpha, inhibitors |
| 07/05/2001 | CA2396579A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | CA2396502A1 Substituted pyrrole mannich bases |
| 07/05/2001 | CA2395543A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | CA2395259A1 Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect |
| 07/05/2001 | CA2395249A1 Substituted piperazine derivatives, the preparation thereof and their use as medicaments |
| 07/05/2001 | CA2394944A1 Combinations of a receptor tyrosine kinase inhibitor with an organic compound capable of binding to .alpha.1-acidic glycoprotein |
| 07/05/2001 | CA2394727A1 Pyrimidine and triazine kinase inhibitors |
| 07/05/2001 | CA2394097A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias |
| 07/05/2001 | CA2392866A1 Substituted indole mannich bases |
| 07/05/2001 | CA2363274A1 Fused-ring compounds and use thereof as drugs for hepatitis c |
| 07/04/2001 | EP1113332A1 Photographic element, compound, and process |
| 07/04/2001 | EP1113014A1 Linear or cyclic ureas, a process for their preparation and pharmaceutical compositions containing them |
| 07/04/2001 | EP1113007A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 07/04/2001 | EP1112741A1 Use of protease inhibitors for the treatment of necrotizing infections |
| 07/04/2001 | EP1112456A1 Tube for lining pipes and channels, and a method and device for the production thereof |
| 07/04/2001 | EP1112284A1 Piperazine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p53 |
| 07/04/2001 | EP1112266A1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 07/04/2001 | EP1112265A1 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine |
| 07/04/2001 | EP1112256A1 Cyclohexenonquinolinoyl-derivatives as herbicidal agents |
| 07/04/2001 | EP1112255A1 4,4-biarylpiperidine derivatives with opioid receptor activity |
| 07/04/2001 | EP1112252A1 Kappa agonist compounds and pharmaceutical formulations thereof |
| 07/04/2001 | EP1112251A1 Azetidine derivatives, preparation and medicines containing them |
| 07/04/2001 | EP1112074A1 Taurolidine and/or taurultam against infectious ulcer or gastritis |
| 07/04/2001 | EP1112071A1 Growth hormone secretagogues |
| 07/04/2001 | EP1112070A1 Novel substituted triazole compounds |
| 07/04/2001 | EP1019379A4 Peroxide-based chemiluminescent assays and chemiluminescent compounds used therein |
| 07/04/2001 | EP0850236B1 Piperazino derivatives as neurokinin antagonists |
| 07/04/2001 | CN1302297A Pyrimidin-aminomethyl-pyridine derivatives, their preparation and their use in control of helicobacter bacteria |
| 07/04/2001 | CN1302296A Novel 2-alkyl substituted imidazole compounds |
| 07/04/2001 | CN1302292A Aminoisoquinoline derivatives |
| 07/04/2001 | CN1302290A Selective anti-mycobacterial preparations, method for producing the same and pharmaceutical compositions |
| 07/04/2001 | CN1302206A Therapeutic uses of quinoline derivatives |
| 07/04/2001 | CN1302184A Composition for keeping away vermin |
| 07/04/2001 | CN1301701A Camptothecine like compound, its preparing method and medicinal composition containing them |
| 07/04/2001 | CN1301699A New direct chain or cyclic urea, its preparing method and medicinal composition containing them |
| 07/04/2001 | CN1068001C Heterocycle substituted propenoid acid derivatives as NMDA antagonists |
| 07/04/2001 | CN1067999C Anti-helicobacter heterocyclic derivatives of azolines |
| 07/04/2001 | CN1067992C Substituted thiazolidine derivatives and pharmaceutical compounds containing them and use thereof |
| 07/04/2001 | CN1067989C New compound with analgesic and local anaesthetic effect |
| 07/04/2001 | CN1067986C 1H-indole-3-acetic acid hydrazide phospholipid enzyme A2 inhibitors |
| 07/03/2001 | US6255494 Substituted benzimidazoles useful in treating or preventing conditions associated with excess of neuropeptide y (around arteries in heart, respiratory tract, gastrointestinal tract and genitourinary tract); etiology of psychiatric disorders |
| 07/03/2001 | US6255491 Synthesis of intermediate compounds for 4-adyl-5-pyrimidine imidazole substituted derivatives |
| 07/03/2001 | US6255489 Method for producing (hetero)aromatic hydroxylamines |
| 07/03/2001 | US6255342 Pesticides |
| 07/03/2001 | US6255334 5HT 1 receptor agonists and metoclopramide for the treatment of migraine |
| 07/03/2001 | US6255323 Anticancer agents |
| 07/03/2001 | US6255322 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents |
| 07/03/2001 | US6255318 Antiviral compounds |
| 07/03/2001 | US6255315 Alpha 1a adrenergic receptor antagonists |
| 07/03/2001 | US6255306 4-indole derivatives as serotonin agonists and antagonists |
| 07/03/2001 | US6255302 Nervous system, psychological disorders |
| 07/03/2001 | US6255301 Amino acid derivatives and their use as thrombin inhibitors |
| 07/03/2001 | US6255091 Potentiating metal mediated serine protease inhibitors with cobalt or zinc ions |
| 07/03/2001 | CA2216231C Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 07/03/2001 | CA2141704C Concentrated aqueous argatroban solutions |
| 07/03/2001 | CA2037630C Nitrogen-containing heterocylic compounds, their production and use |
| 06/29/2001 | CA2293913A1 Treatment of necrotizing infections |
| 06/28/2001 | WO2001046263A1 Novel compounds |
| 06/28/2001 | WO2001046200A1 Novel piperidine and piperazine derivatives |
| 06/28/2001 | WO2001046181A1 Indole derivatives for the treatment of depression and anxiety |
| 06/28/2001 | WO2001046178A2 Substituierte bisindolymaleimide |
| 06/28/2001 | WO2001046173A1 SELECTIVE iGLUR5 RECEPTOR ANTAGONISTS |
| 06/28/2001 | WO2001046172A1 Pyrazole cyclic amp-specific pde inhibitors |
| 06/28/2001 | WO2001046156A1 Butyne diol derivatives |
| 06/28/2001 | WO2001046151A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 06/28/2001 | WO2001046138A1 Inhibitors of farnesyl protein transferase |
| 06/28/2001 | WO2001046137A1 Farnesyl transferase inhibitors |
| 06/28/2001 | WO2001045711A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | WO2001045709A1 Substituted piperazine and piperidine calcium channel blockers |
| 06/28/2001 | WO2001045702A1 SUBSTITUTED ACYLHYDROXAMIC ACIDS AND METHOD OF REDUCING TNFα LEVELS |
| 06/28/2001 | WO2001045700A1 Urotensin-ii receptor antagonists |
| 06/28/2001 | WO2001045688A2 Use od desloratadine for treating allergic and inflammatory conditions in pediatric patients |
| 06/28/2001 | WO2001045687A2 Use of bioactive metabolites of gepirone for the treatment of psychological disorders |
| 06/28/2001 | WO2001045637A2 Novel 4(piperazinyl (8-quinolinyl)metyl)benzamides |
| 06/28/2001 | WO2001010834A3 Antibacterial agents |
| 06/28/2001 | WO2000071171A3 Sigma-1 ligands for determining carcinoma proliferative status |
| 06/28/2001 | WO1999063937A9 Multivalent macrolide antibiotics |
| 06/28/2001 | DE19962936A1 New beta-aminoacid amide derivatives, are integrin antagonists useful for treating inflammatory, autoimmune or immunological disorders e.g. asthma, diabetes or rheumatoid arthritis |